Search Results

Terry Kenakin to elevate your science and sharpen your calls. Kenakin is today, September 18th, 12-1 pm EST in Terry’s Corner. Corner members get to rewatch the recording Subscribe to the Kenakin Brief and Join the Live AMA ➤ Celtarys Kenakin is a leading expert in the field. Kenakin is a masterful teacher and communicator." — DrGPCR University Attendee Everything you need to

Kenakin dissects how P450s can be both protective and problematic. Terry Kenakin This Month’s Live AMA — October 30 at 12 PM EST Join Dr. Kenakin live for an open Q&A session designed for discovery scientists. Kenakin with your own enzyme or GPCR interaction puzzles. Subscribe to The Kenakin Brief  today ➤

Terry Kenakin walks through the core early assays that protect your chemistry, budget, and timeline. Kenakin takes place February 26 at 12:00 PM EST. Subscribe to the free Kenakin Brief Newsletter to join the AMA . Terry Kenakin at a significantly reduced cost. This is not commentary.

Terry Kenakin ; GIP receptor agonist patent WO2025264700. 🔍 This Week in Dr.GPCR Premium: Sneak Peek Terry Kenakin reframes PK as a predictive, manageable discipline , not an unavoidable bottleneck. Here's how: Watch the course trailer ➤ Read the blog post ➤ Subscribe to the Kenakin Brief ➤ Dr.

But Terry Kenakin’s new Emerging Drug Hunter lecture reveals why this assumption can mislead even experienced Wasted optimization efforts Focus on leads that fail later in development In this exclusive session, Kenakin Kenakin shows exactly how to separate what matters from what misleads—practical, real-world expertise Kenakin. I wish Dr.

Kenakin reveals how Schild’s equation became the first real “receptor test”—a filter that separates mechanistic Kenakin emphasizes, “Schild plots don’t just confirm competition—they expose when competition is an illusion In Kenakin's words, “Every slope, every curvature, every failure to fit—those are the whispers of the Terry Kenakin, monthly AMAs, and a growing on-demand library help scientists sharpen fundamentals, challenge

Terry Kenakin, and catch up on cutting-edge insights through our full library of symposia recordings, Terry Kenakin.

In this exclusive Expert Drug Hunter lesson, Terry Kenakin dismantles 100 years of receptor theory and

Terry Kenakin’s newest foundational lesson in Terry's Corner  cuts straight to it:   Why models are vital

Kenakin  will get released next month, featuring real questions from discovery scientists tackling enzyme Kenakin Content trusted by biotech, pharma, and academia 💎 $2999/year — one conference cost = a full Kenakin with your own enzyme or GPCR interaction puzzles. Subscribe to The Kenakin Brief  today ➤

Terry Kenakin reframes one of pharmacology’s most foundational ideas: the difference between competitive Terry Kenakin Monthly Ask‑Me‑Anything sessions with live Q&A An expanding on‑demand library for novices Subscribe to The Kenakin Brief today  ➤   #GPCRantagonism #CompetitiveAntagonists #NonCompetitiveAntagonists

In this live AMA, Terry Kenakin will the methods that differentiate these binding modes and why this Send us your questions ahead of time at Terry@DrGPCR.org Free for Kenakin Brief subscribers. Library This week's featured course from the Masterclass Library: Unconventional GPCR Ligands with Terry Kenakin

Kenakin breaks down why Schild analysis remains the gold standard for verifying true competition — and Kenakin is a leading expert in the field. Kenakin is a masterful teacher and communicator.”

In the newest foundational lesson from Terry Kenakin’s Pharmacology Vault , we unlock the visual language

In this eye-opening module, Terry Kenakin explores a concept that could change how you interpret pharmacological

Terry Kenakin to elevate your science and sharpen your decisions. Terry Kenakin delivers a game-changing framework for teams grappling with the gap between in vitro potency To stay in the know on upcoming courses and AMA session, get the complementary Kenakin Brief , the weekly Kenakin) teaming up with the best GPCR community platform to help train and inspire the next generation

In Terry Kenakin’s latest lesson, you’ll uncover why efficacy is the unsung hero of drug discovery and

In his newest lesson, “The Uniqueness of Pharmacology in Drug Discovery,” Terry Kenakin explains why

Kenakin highlights how hybrid molecules  — combining two pharmacophores into one scaffold — enable dual-modality Terry Kenakin, monthly AMA discussions, and on-demand access to a library of expert GPCR teaching sessions to understand. 40 years of expertise at your fingertips: Explore the full library ➤ Subscribe to the Kenakin

Terry Kenakin , a veteran pharmacologist with over 40 years of industry experience.

Kenakin — October 30, 12 PM EST Bring your toughest pharmacology questions and join Dr. Kenakin live. Each session shapes next month’s lessons—so your challenges guide the content. Kenakin Trusted insights across biotech, pharma, and academia 💎 $2,999/year — one conference cost =

Kenakin himself for deeper dives   A new lesson will drop every Tuesday, ensuring fresh insights are

Kenakin walks through this as a living system , showing how GPCRs exist in multiple conformations and Kenakin     💎 $2999/year — one conference cost = 12 months of expert training  Premium Dr. Subscribe to The Kenakin Brief  today ➤

Terry Kenakin. The course covers basic pharmacology in four weekly segments. Kenakin, according to his availability Access to the cohort’s Dr. Kenakin and your classmates Access to the course materials and recordings Course completion certificate Kenakin and Dr. GPCR Complimentary one-year Dr.

Terry Kenakin’s latest lecture in Terry’s Corner  delivers exactly what your discovery teams need now Kenakin is a masterful teacher and communicator—and a leading expert in our field.” — Dr. Terry Kenakin’s featured talk on “The Kinetics of Allostery” offers a rare live glimpse into advanced

Terry Kenakin. The course covers basic pharmacology in four weekly segments. Only ten spots remain. Kenakin, according to his availability Access to the cohort’s Dr. Kenakin and your classmates Access to the course materials and recordings Course completion certificate Kenakin and Dr. GPCR Complimentary one-year Dr.

Terry Kenakin  and Sam Hoare ! Terry Kenakin to gain insights and prepare for upcoming courses. Kenakin's upcoming courses. Our goal is to ensure that education is within reach for everyone!

From Bench Insight to Strategic Advantage Terry Kenakin’s decades of pharmacology leadership converge Kenakin Content trusted by biotech, pharma & academia 💎 $2999/year — one conference cost = a full Subscribe to The Kenakin Brief  today ➤

Terry Kenakin, starts February 8th, 2024. Due to popular demand, we have opened additional spots. Kenakin in a small group setting, hurry and register today. Only three spots remain. Kenakin Access to the cohort’s Dr. Kenakin and Dr. GPCR Complimentary one-year Dr.

Terry Kenakin. The course covers basic pharmacology in four weekly segments. Kenakin, according to his availability Access to the cohort’s Dr. Kenakin and your classmates Access to the course materials and recordings once the course is completed Kenakin and Dr. GPCR Access to Dr.